Roche Opens Direct Response Buying Review

Share this article:
Pharmaceutical giant Roche, Nutley, NJ, has launched a review to choose an agency that will buy direct response media for its Tamiflu influenza pill.


Agencies participating in the review include Young & Rubicam's Impiric, which handles direct response buying for Tamiflu; Initiative Media's Media Direct Partners; and Media Marketing Solutions, also owned by Y&R.


AAR/Bob Wolf Partners, New York, is the advertising consultant on the review. The decision is due in October.
Share this article:
You must be a registered member of Direct Marketing News to post a comment.
close

Next Article in Agency

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs: